G. Walsh and . Biopharmaceutical, Nat. Biotechnol, vol.36, pp.1136-1145, 2018.

J. Schuurman and P. W. Parren, Editorial overview: Special section: New concepts in antibody therapeutics: What's in store for antibody therapy?, Curr. Opin. Immunol, vol.40, 2016.

C. G. Siontorou, Nanobodies as novel agents for disease diagnosis and therapy, Int. J. Nanomed, vol.8, 2013.

A. L. Nelson, E. Dhimolea, and J. M. Reichert, Development trends for human monoclonal antibody therapeutics, Nat. Rev. Drug Discov, vol.9, pp.767-774, 2010.

J. M. Woof and D. R. Burton, Human antibody-Fc receptor interactions illuminated by crystal structures, Nat. Rev. Immunol, vol.4, pp.89-99, 2004.

R. J. Keizer, A. D. Huitema, J. H. Schellens, and J. H. Beijnen, Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies. Clin. Pharmacokinet, vol.49, pp.493-507, 2010.

G. M. Thurber, M. M. Schmidt, and K. D. Wittrup, Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance, Adv. Drug Deliv. Rev, vol.60, pp.1421-1434, 2008.

P. Holliger and P. J. Hudson, Engineered antibody fragments and the rise of single domains, Nat. Biotechnol, vol.23, pp.1126-1136, 2005.

W. Wang, E. Wang, and . Balthasar, J. Monoclonal Antibody Pharmacokinetics and Pharmacodynamics. Clin. Pharmacol. Ther, vol.84, pp.548-558, 2008.

D. K. Shah and A. M. Betts, Antibody biodistribution coefficients: Inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human, vol.5, pp.297-305, 2013.

S. Goswami, W. Wang, T. Arakawa, and S. Ohtake, Developments and Challenges for mAb-Based Therapeutics, Antibodies, vol.2, pp.452-500, 2013.

P. G. Swann, M. Tolnay, S. Muthukkumar, M. A. Shapiro, B. L. Rellahan et al., Considerations for the development of therapeutic monoclonal antibodies, Curr. Opin. Immunol, vol.20, pp.493-499, 2008.

A. L. Nelson, Antibody fragments: Hope and hype. mAbs, vol.2, pp.77-83, 2010.

I. Vaneycken, J. Govaert, C. Vincke, V. Caveliers, T. Lahoutte et al., In Vitro Analysis and In Vivo Tumor Targeting of a Humanized, Grafted Nanobody in Mice Using Pinhole SPECT/Micro-CT, J. Nucl. Med, vol.51, pp.1099-1106, 2010.

T. Yokota, D. E. Milenic, M. Whitlow, and J. Schlom, Rapid Tumor Penetration of a Single-Chain Fv and Comparison with Other Immunoglobulin Forms, Cancer Res, vol.52, pp.3402-3408, 1992.

R. Vazquez-lombardi, T. G. Phan, C. Zimmermann, D. Lowe, L. Jermutus et al., Challenges and opportunities for non-antibody scaffold drugs, Drug Discov. Today, vol.20, pp.1271-1283, 2015.

J. M. Pérez, J. G. Renisio, J. J. Prompers, C. J. Van-platerink, C. Cambillau et al., Thermal Unfolding of a Llama Antibody Fragment: A Two-State Reversible Process ?, Biochemistry, vol.40, pp.74-83, 2001.

E. D. Lobo, R. J. Hansen, and J. P. Balthasar, Antibody Pharmacokinetics and Pharmacodynamics. J. Pharma. Sci, vol.93, pp.2645-2668, 2004.

J. Li and D. J. Mooney, Designing hydrogels for controlled drug delivery, Nat. Rev. Mater, 2016.

S. Lanzalaco and E. Armelin, Poly(N-isopropylacrylamide) and Copolymers: A Review on Recent Progresses in Biomedical Applications, vol.3, p.36, 2017.

G. Dumortier, J. L. Grossiord, F. Agnely, and J. C. Chaumeil, A Review of Poloxamer 407 Pharmaceutical and Pharmacological Characteristics, Pharm. Res, vol.23, pp.2709-2728, 2006.

K. Y. Lee and D. J. Mooney, Alginate: Properties and biomedical applications, Prog. Polym. Sci, vol.37, pp.106-126, 2012.

L. W. Kleiner, J. C. Wright, and Y. Wang, Evolution of implantable and insertable drug delivery systems, J. Control. Release, vol.181, pp.1-10, 2014.

Y. Wang, L. Sun, Z. Mei, F. Zhang, M. He et al., 3D printed biodegradable implants as an individualized drug delivery system for local chemotherapy of osteosarcoma, Mater. Des, vol.186, 2020.

E. Chabrol, J. Stojko, A. Nicolas, T. Botzanowski, B. Fould et al., VHH characterization.Recombinant VHHs: Production, characterization and affinity, Anal. Biochem, vol.589, 2020.
URL : https://hal.archives-ouvertes.fr/hal-02341567

P. Kunz, K. Zinner, N. Mücke, T. Bartoschik, S. Muyldermans et al., The structural basis of nanobody unfolding reversibility and thermoresistance, Sci. Rep, vol.8, 2018.

T. Liu and B. Chu, Formation of homogeneous gel-like phases by mixed triblock copolymer micelles in aqueous solution: FCC to BCC phase transition, J. Appl. Crystallogr, vol.33, 2000.

D. Schweizer, K. Schönhammer, M. Jahn, and A. Göpferich, Protein-Polyanion Interactions for the Controlled Release of Monoclonal Antibodies, Biomacromolecules, vol.14, pp.75-83, 2013.

V. Rahmani and H. Sheardown, Protein-alginate complexes as pH-/ion-sensitive carriers of proteins, Int. J. Pharm, vol.535, pp.452-461, 2018.

D. Hsiao, S. Hsu, R. Chen, and M. Chen, Characterization of designed directional polylactic acid 3D scaffolds for neural differentiation of human dental pulp stem cells, J. Formos. Med. Assoc, vol.119, pp.268-275, 2020.

. Cablivi, , p.24, 2018.

L. Nouchikian, C. Roque, J. Y. Song, N. Rahman, and S. F. Ausar, An intrinsic fluorescence method for the determination of protein concentration in vaccines containing aluminum salt adjuvants, vol.36, pp.5738-5746, 2018.

S. Ohtake, Y. Kita, and T. Arakawa, Interactions of formulation excipients with proteins in solution and in the dried state, Adv. Drug Deliv. Rev, vol.63, pp.1053-1073, 2011.

D. Schweizer, T. Serno, and A. Goepferich, Controlled release of therapeutic antibody formats, Eur. J. Pharm. Biopharm, vol.88, pp.291-309, 2014.

S. Mitragotri, P. A. Burke, and R. Langer, Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies, Nat. Rev. Drug Discov, vol.13, pp.655-672, 2014.

C. Boland, S. Olatunji, J. Bailey, N. Howe, D. Weichert et al., Membrane (and Soluble) Protein Stability and Binding Measurements in the Lipid Cubic Phase Using Label-Free Differential Scanning Fluorimetry, Anal. Chem, vol.90, pp.12152-12160, 2018.

V. Kotov, K. Bartels, K. Veith, I. Josts, U. K. Subhramanyam et al., High-throughput stability screening for detergent-solubilized membrane proteins, Sci. Rep, vol.9, 2019.

A. O. Magnusson, A. Szekrenyi, H. Joosten, J. Finnigan, S. Charnock et al., nanoDSF as screening tool for enzyme libraries and biotechnology development, FEBS J, vol.286, pp.184-204, 2019.

D. S. Goldberg, S. M. Bishop, A. U. Shah, and H. A. Sathish, Formulation Development of Therapeutic Monoclonal Antibodies Using High-Throughput Fluorescence and Static Light Scattering Techniques: Role of Conformational and Colloidal Stability, J. Pharm. Sci, vol.100, pp.1306-1315, 2011.

K. Ward, J. G. Cortés, and D. Stuckey, Alginate as a support ligand for enhanced colloidal liquid aphron immobilization of proteins and drug delivery, Biotechnol. Bioeng, vol.116, pp.3168-3178, 2019.

N. Pandit, Loss of gelation ability of Pluronic ® F127 in the presence of some salts, Int. J. Pharm, vol.145, pp.129-136, 1996.

S. C. Miller and B. R. Drabik, Rheological properties of poloxamer vehicles, Int. J. Pharm, vol.18, pp.269-276, 1984.

R. H. Van-der-linden, L. G. Frenken, B. De-geus, M. M. Harmsen, R. C. Ruuls et al., Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies, Biochimica et Biophysica Acta (BBA)-Protein Struct. Mol. Enzymol, pp.37-46, 1431.

P. Kunz, A. Ortale, N. Mücke, K. Zinner, and J. D. Hoheisel, Nanobody stability engineering by employing the ?Tm shift; a comparison with apparent rate constants of heat-induced aggregation, Protein Eng. Des. Sel, vol.32, pp.241-249, 2019.